We realized the need to scale rapidly as we have gained traction throughout the year with our MDR service,” said Prakash Panjwani, CEO of WatchGuard Technologies. “The acquisition of ActZero allows ...

How employees can transform from security risks into frontline defenders.

Yun Zhong, an analyst from Wedbush, maintained the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The associated price target ...